15.500
−0,32%
2026-10-16
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +73.3% | +456.7% | 3 / 3 | +35.4% | +1.17 pp | +0.79 pp | +9.0% | 0.45 | 11.02 | 735 | +35,4% | 44,1 | +55,9% | 11.02 | 31.18 | −64,7% |
| Pts | 12 | 12 | 12 | 12 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 15.500 (close price on 2026-10-16)EPS (TTM): 1.407
Financial charts
1.Revenue & growth
VND bn735Q2/26
1.Revenue & growth
VND bn735Q2/26
2.Profit & growth
VND bn33,8Q2/26
3.Profit mix (Penman)
VND bn216Q2/26
4.Margins & cost structure
%18.5%Q2/26
5.Returns & cash cycle
% · days9.6%Q2/26
6.Earnings quality & cash
VND bn389Q2/26
7.Asset structure
VND bn3.976Q2/26
8.Funding & debt health
VND bn · times3.976Q2/26
9.Revenue backlog
VND bn123Q2/26
10.Valuation
times · %11,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %373Q2/26
Adjusted EPS growth, latest quarter
73.3%
Average adjusted EPS growth, 3 quarters
146%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26